Aurora Cannabis Reports Q3 Revenue Growth Slows, Consumer Sales Remain Under Pressure

Aurora Cannabis reported Q3 medical cannabis revenue growth slowdown and ongoing consumer sales pressure. Medical cannabis revenue increased 21% YoY, while consumer sales declined 7% YoY. The company's net loss narrowed to $147.2 million, compared to a loss of $257.3 million in Q3 2021. Aurora's medical cannabis sales growth was driven by strong demand in the US and Europe, while consumer sales were impacted by a decline in Canadian market share.